Cost-effectiveness analysis of interventions for congenital heart disease.
Expansion of the options available for the treatment of congenital heart disease has been accompanied by an increasing realization of the limits of our available health care resources. Cost-effectiveness analysis is one of several analytic approaches that can improve decisions about the appropriate use of technology in interventional pediatric cardiology and other fields. In this article, cost-effectiveness analysis is distinguished from related approaches, such as cost-benefit analysis. Then, basic principles of cost-effectiveness analysis are described. Next, the application of these principles is illustrated, using a recently published comparison of transcatheter versus surgical closure of patent ductus arteriosus. Finally, potential research implications of the surprising findings of this study are discussed.
Gray
D T
DT
Section of Clinical Epidemiology, Mayo Clinic, Rochester, Minnesota 55905, USA.
D006328:Cardiac Catheterization / Q000191:economics*; D002648:Child; D003362:Cost-Benefit Analysis; D006330:Heart Defects, Congenital / Q000191:economics* / Q000601:surgery / Q000628:therapy; D006801:Humans; D007223:Infant